Jacques Neefjes

Has grant

Professor, head department

Leiden University Medical Center
Country flagNetherlands

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jacques Neefjes is a Professor and Head of Department at Leiden University Medical Center in the Netherlands. His research focuses on innovative drug delivery strategies in glioblastoma, the development of antitumor agents, and the role of chromatin in cancer therapies. He has contributed significantly to the understanding of MHC-I binding and has explored metabolic engineering for anticancer drug biosynthesis. His recent work also includes the assessment of cardiotoxicity and epigenetic regulation in tumor cells.

Recent Grants

Grant: Close

Reintroducing aclarubicin in the treatment of relapsed and refractory AML patients

Open Date: 2018-07-01

Close Date: 2021-07-01

Grant: Close

Bacterial food poisoning and colon cancer; a cell biological and epidemiological study

Open Date: 2017-11-01

Close Date: 2021-11-01

Grant: Open

Oncology research

Open Date: 2017-01-01

Close Date: 2027-01-01

Grant: Close

ERC Adv Grant ER control of endosomal positioning

Open Date: 2016-09-01

Close Date: 2021-09-01

Grant: Close

The Institute for Chemical Immunology

Open Date: 2014-02-01

Close Date:

Articles (20)

Chromatinized DNA is targeted by proteins and small molecules to regulate chromatin function. For example, anthracycline cancer drugs evict nucleosomes in a mechanism that is still poorly understood. We here developed a flexible method for specific isotope labeling of nucleosomal DNA enabling NMR studies of such nucleosome interactions. We describe the synthesis of segmental one‐strand 13 C‐thymidine labeled 601‐DNA, the assignment of the methyl signals, and demonstrate its use to observe site‐specific binding to the nucleosome by aclarubicin, an anthracycline cancer drug that intercalates into the DNA minor grooves. Our results highlight intrinsic conformational heterogeneity in the 601 DNA sequence and show that aclarubicin binds an exposed AT‐rich region near the DNA end. Overall, our data point to a model where the drug invades the nucleosome from the terminal ends inward, eventually resulting in histone eviction and nucleosome disruption.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Sérgio F de Almeida

Universidade do Porto Faculdade de Medicina

PORTUGAL
View details

Birol Cabukusta

Group leader / Assistant professor

University of Maastricht

NETHERLANDS
View details

Katerina Gurova

Associate Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Ramon Arens

Associate Professor

Leiden University Medical Center

NETHERLANDS
View details

Johanna H Meijer

Professor

Leiden University Medical Center

NETHERLANDS
View details

Yassene Mohammed

University of Victoria

CANADA
View details

Benedikt Kessler

Professor of Biochemistry and Life Science Mass Spectrometry

University of Oxford

UNITED KINGDOM
View details

Steven Henikoff

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Tom DeBoer

Associate professor

Leiden University Medical Center

NETHERLANDS
View details

Luis Moita

Associate Professor

Universidade Autónoma de Lisboa

PORTUGAL
View details

Raffaella Gozzelino

NOVA University of Lisbon

PORTUGAL
View details

Hugo van Ingen

-

NETHERLANDS
View details

Mirjam H.M. Heemskerk

Associate professor, Head of Laboratory of experimental hematology

Leiden University Medical Center

NETHERLANDS
View details

Jeroen T. Buijs

Leiden University Medical Center

NETHERLANDS
View details

Somayah Elsayed

Assistant Professor

Universiteit Leiden Instituut Biologie Leiden

NETHERLANDS
View details

Ana Marcu

University of Tübingen

GERMANY
View details

Ilana Berlin

-

NETHERLANDS
View details

Ferenc Scheeren

Leiden University Medical Center

NETHERLANDS
View details

Ana Messias

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.